Immediate Impact
18 standout
Citing Papers
Development of NK cell-based cancer immunotherapies through receptor engineering
2024 Standout
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
2023 Standout
Works of Mahmoud Hammad being referenced
COVID-19 Pandemic Development in Jordan—Short-Term and Long-Term Forecasting
2021
Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mahmoud Hammad | 64 | 23 | 17 | 66 | 28 | 30 | 176 | |
| Canan Vergin | 83 | 27 | 36 | 35 | 33 | 38 | 256 | |
| Koray Yalçın | 42 | 22 | 11 | 38 | 16 | 27 | 160 | |
| Thayne Woycinck Kowalski | 56 | 13 | 32 | 112 | 25 | 46 | 291 | |
| Lisandro Ribeiro | 100 | 47 | 43 | 92 | 20 | 23 | 255 | |
| Chepsy C Philip | 91 | 47 | 47 | 40 | 25 | 19 | 207 | |
| Kyung Taek Hong | 48 | 28 | 19 | 25 | 37 | 51 | 152 | |
| Tomoko Yokosuka | 56 | 63 | 45 | 49 | 24 | 27 | 261 | |
| Atsuko Mugitani | 90 | 77 | 26 | 39 | 35 | 28 | 214 | |
| H Matsukura | 49 | 41 | 17 | 44 | 59 | 29 | 282 | |
| Kota Yoshifuji | 53 | 47 | 11 | 107 | 25 | 27 | 192 |
All Works
Login with ORCID to disown or claim papers
Loading papers...